300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Madagascar
Isle of Man
Lesotho
Romania
Pakistan
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Costa Rica
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Qatar
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Spain
Mongolia
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 10 Biotech Startup Investors in Latvia (September 2026)

The most active venture capital funds and angel investors investing in Latvia Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Latvia Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Imprimatur Capital Fund Management
VC Fund
5 Latvia, United States, United Kingdom Seed, Debt Financing Software, Information Technology, Apps $55k–$633k
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Abingworth
VC Fund
2 United States, United Kingdom, France Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $14M–$120M
Inovo.vc
VC Fund
2 Poland, United States, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $300k–$23M
Qiming Venture Partners USA
VC Fund
2 United States, Canada, China Series A, Series B, Seed Biotechnology, Health Care, Pharmaceutical $6M–$116M
FlyCap
VC Fund
2 Latvia, Estonia, The Netherlands Seed, Debt Financing Health Care, Rental, Medical $55k–$2.9M
Surveyor Capital
VC Fund
1 United States, China, Canada Series B, Post-IPO Equity, Series C Biotechnology, Health Care, Therapeutics $41M–$280M
TSVC
VC Fund
1 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$44M
Alexandria Venture Investments
VC Fund
1 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
Citadel
VC Fund
1 United States, India, Spain Private Equity, Series C, Seed Information Technology, Biotechnology, Health Care $650k–$2B
Access all 56 investors in Latvia Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Imprimatur Capital Fund Management
VC Fund · Riga, Riga, Latvia · 5 investments in Latvia Biotech startups

Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Debt Financing
  • Geography: Latvia, United States, United Kingdom

Investor stats

  • Total investments: 83
  • Round size: Seed $127k–$633k; Debt Financing $55k–$70k
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $12M in 2010

Portfolio highlights

  • Axial3D — Leading the way with the latest 3D imaging, models, and devices
  • afriQloud — AfriQloud provides a white-labeled cloud computing solution to telecom operators, internet service providers, system integrators, and managed information technology service providers.
  • Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Latvia Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Abingworth
VC Fund · London, England, United Kingdom · 2 investments in Latvia Biotech startups

We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 176
  • Round size: Series A $14M–$115M; Series B $18M–$95M; Series C $20M–$120M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $356M in 2023

Portfolio highlights

  • Iambic — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
  • cAMPfield Therapeutics — cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
  • Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Show all investments...

Inovo.vc
VC Fund · Warsaw, Mazowieckie, Poland · 2 investments in Latvia Biotech startups, 7 in the past 12 months

VC for the most ambitious founders in CEE

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Poland, United States, United Kingdom

Investor stats

  • Total investments: 101
  • Round size: Seed $300k–$9.9M; Pre-Seed $700k–$3.4M; Series A $1.7M–$23M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely still investing — raised $107M in 2022

Portfolio highlights

  • Yope — Salo is a discussion platform that erases the borders for people with diverse opinions to let anyone speak up and be heard.
  • Ingenix — Ingenix is building an AI Co-pilot for generating real-time hypotheses on clinical endpoints values and adverse events.
  • Nanogram — Nanogram is an AI-powered gaming startup that creates an instant prompt-to-game platform, allowing anyone to build and share interactive short-form video games. Frequently described as "TikTok for mobile games," the company delivers an endless, vertical social feed of byte-sized, zero-download games that players swipe through and playinstantly.
Show all investments...

Qiming Venture Partners USA
VC Fund · Cambridge, Massachusetts, United States · 2 investments in Latvia Biotech startups

Qiming Venture Partners USA, founded in 2017, is a healthcare venture capital firm and healthcare investor with deep technical expertise that allows them to identify tomorrow's innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.Because of theirproven, hands-on approach to supporting CEOs and scaling operations, its partners are frequently sought after to serve on company boards. They are respected business and thought leaders.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, China

Investor stats

  • Total investments: 40
  • Round size: Seed $6M–$55M; Series A $14M–$92M; Series B $36M–$116M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: Likely still investing — raised $260M in 2022

Portfolio highlights

  • Dualitas Therapeutics — Dualitas Therapeutics is a biotechnology company pioneering best-in-class, next-generation bispecific antibodies for immune and inflammatory diseases and beyond.
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
  • Rhino Federated Computing — Rhino Federated Computing solves one of the biggest challenges in AI: seamlessly connecting siloed data through federated computing.
Show all investments...

FlyCap
VC Fund · Riga, Riga, Latvia · 2 investments in Latvia Biotech startups

FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.

Show more...

Investment focus

  • Industry: Health Care, Rental, Medical
  • Stage:Seed, Debt Financing
  • Geography: Latvia, Estonia, The Netherlands

Investor stats

  • Total investments: 30
  • Round size: Seed $55k–$2.9M; Debt Financing $329k–$2.2M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $18M in 2013

Portfolio highlights

  • Mintos — Mintos is a platform that provides retail investors with an accessible way to build wealth through loan-based investments. Through their platform retail investors can invest in a diversified way in income-producing assets to build wealth in the long term. They implement environmental, social, and employee matters, respect for human rights,anti‐corruption, and anti‐bribery matters within their remuneration policy practices and other internal company documents.
  • Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
  • Elmo — In our mobility-focused operations, we wanted to optimize business and decrease environmental impact, so we created remote control technology to deliver cars.
Show all investments...

Surveyor Capital
VC Fund · Chicago, Illinois, United States · 1 investments in Latvia Biotech startups, 9 in the past 12 months

Surveyor Capital is a fundamental equities business. Surveyor’s sector-aligned investment teams aim to generate alpha through a deep understanding of each company’s strategy, management teams, drivers of performance, and cyclical and secular industry trends over the medium and long term.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Post-IPO Equity, Series C
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 172
  • Round size: Series B $60M–$170M; Series C $60M–$200M; Post-IPO Equity $41M–$280M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Sol-Gel Technologies — Sol-Gel designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
  • Perspective Therapeutics — Perspective Therapeutics is dedicated to finding the best ways to deliver remedies to patients and their medical needs, and they believe in a targeted, individualized approach to cancer treatment. We design treatments that are given exactly where the doctor needs them.
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 1 investments in Latvia Biotech startups

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 341
  • Round size: Seed $500k–$6.3M; Series A $2.7M–$44M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely actively investing — fresh fund, raised $20M in 2026

Portfolio highlights

  • Nvigen — NVIGEN is revolutionizing personalized medicine with highly accurate and NGS data efficient assays that provide integrative DNA, RNA, protein, cell, exosome information. Our mission is to improve health through our open platform of molecularly engineered nanoparticles and data-driven insights that help understand biological processes and reduce risks for aging, cancer, cardiovascular, neurodegenerative, and diabetic conditions.The NVIGEN X - Cancer Precision Profiling Test, now available for research use, supports early detection, monitoring, and treatment of cancer through accessible liquid biopsy tests. In line with our OpenVigen philosophy, we offer MagVigen and MyQuVigen nanoparticles to the biotech community, enabling high-sensitivity and high specificity immunoassays, genomic testing, molecular and cellular capture, and multiomics analysis. These products empower advancements in biomarker profiling, point-of-care testing, T-cell therapy, and precision diagnostics.
  • Dexmate — Dexmate is a robotics startup focused on developing general-purpose mobile robots. The company specializes in robots with manipulation capabilities. Their technology aims to enhance automation across various industries.
  • EGI Battery — EGI Battery is an American advanced battery cell manufacturer headquartered with design and operations in Ann Arbor, Michigan, U.S.
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 1 investments in Latvia Biotech startups, 18 in the past 12 months

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 297
  • Round size: Seed $2M–$30M; Series A $12M–$100M; Series B $25M–$150M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Leal Therapeutics — Leal Therapeutics develops novel therapeutics for patients.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
  • Khartis Therapeutics — Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. The company focuses on discovering and developing drug candidates intended to address chronic conditions and immune-mediated diseases.
Show all investments...

Citadel
VC Fund · Chicago, Illinois, United States · 1 investments in Latvia Biotech startups

We are an alternative investment manager working on behalf of the world's preeminent institutions. Discover our work, teams, careers and more.

Show more...

Investment focus

  • Industry: Information Technology, Biotechnology, Health Care
  • Stage:Private Equity, Series C, Seed
  • Geography: United States, India, Spain

Investor stats

  • Total investments: 20
  • Round size: Seed $650k–$10M; Series C $75M–$2B; Private Equity $11M–$120M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Nscale — Nscale is an AI GPU cloud platform that provides scale computing to the generative AI market. It develops AI-ready data centers, deploys GPU infrastructure, and delivers AI cloud services. Its AI private cloud platform supports the entire generative AI lifecycle, enabling developers to run and train AI models. It also provides bare metal andvirtualized GPU nodes, Kubernetes-native services (NKS), AI workload scheduling empowered by SLURM, and advanced serverless and dedicated inferencing options.
  • Ionic Digital — Discover how Ionic Digital bypasses development bottlenecks to deliver high-performance data center foundations engineered for certainty, scale, and AI growth.
  • Texas Stock Exchange — The Texas Stock Exchange will focus on enabling U.S. and global companies to access U.S. equity capital markets and will provide a venue to trade and list public companies and the growing universe of exchange-traded products. TXSE will be a fully electronic, national securities exchange that will seek registration with the U.S. Securities and Exchange Commission.
Show all investments...

Biotech Investor funding in Latvia at a glance

Stats across 31 deals from 56 investors.

56
investors
in Latvia Biotech startups
31
deals
in Latvia Biotech startups
$532k
median round
in Latvia Biotech startups
36%
lead investors
lead at least one round
32%
Grant
most common funding stage
98/2
VC / Angel
share of investor count

Access all 56 investors in Latvia Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Latvia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 56 investors investing in Latvia Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists